Thursday, May 03, 2018 12:02:38 PM
Today, leading healthcare services and products company, Cardinal Health Inc (NYSE:CAH), is coming under heavy selling pressure after reporting earnings. The stock is trading lower by more than 18.0 percent to $52.73 a share. Traders and investors should note that the stock peaked out in late January when it traded as high as $75.75 a share. Since that pivot high, the stock has been steadily declining making lower highs on the charts. The next major support level for CAH stock will be around the $47.40 level. This is where the stock broke out in July 2013. Often, when a stock declines this sharply it will retest its former breakout level before really stabilizing and moving higher.
Nicholas Ssantiago
InTheMonYStocks
Recent CAH News
- Cardinal Health Board of Directors Approves Increase to Quarterly Dividend • PR Newswire (US) • 05/07/2024 08:15:00 PM
- Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance • PR Newswire (US) • 05/02/2024 10:45:00 AM
- Cardinal Health Reaffirms Fiscal 2024 non-GAAP EPS Guidance and Long-term Targets Amidst Nonrenewal of OptumRx Customer Contracts • PR Newswire (US) • 04/22/2024 10:45:00 AM
- Cardinal Health announces location of pharmaceutical distribution center for over-the-counter products • PR Newswire (US) • 04/02/2024 12:00:00 PM
- Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2024 on May 2 • PR Newswire (US) • 03/26/2024 10:45:00 AM
- Cardinal Health announces approved science-based climate targets; expands focus across the supply chain • PR Newswire (US) • 03/15/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 02:05:42 PM
- Cardinal Health annual research report examines milestone year in biosimilars • PR Newswire (US) • 02/29/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:20:54 PM
- Bob Azelby to join Cardinal Health Board of Directors • PR Newswire (US) • 02/28/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:26:33 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/16/2024 09:20:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 01:55:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 01:51:14 PM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 02/14/2024 09:23:06 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/14/2024 01:53:14 PM
- Cardinal Health Board of Directors Approves Quarterly Dividend • PR Newswire (US) • 02/06/2024 09:35:00 PM
- Cardinal Health publishes Fiscal 2023 Environmental, Social and Governance (ESG) Report • PR Newswire (US) • 02/06/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/01/2024 01:54:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 12:09:06 PM
- Cardinal Health Reports Second Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook • PR Newswire (US) • 02/01/2024 11:45:00 AM
- Cardinal Health to acquire Specialty Networks and its PPS Analytics platform, a technology enabled multi-specialty group purchasing and practice enhancement organization in urology, rheumatology and gastroenterology • PR Newswire (US) • 01/31/2024 11:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 11:48:04 AM
- Cardinal Health Announces Progress on Business and Portfolio Review and Fiscal 2024 Outlook Update • PR Newswire (US) • 01/09/2024 11:45:00 AM
- Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2024 on February 1 • PR Newswire (US) • 01/02/2024 11:55:00 AM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM